Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Bioorg Med Chem. 2019 Nov 11;28(1):115193. doi: 10.1016/j.bmc.2019.115193

Figure 7.

Figure 7.

Kinase selectivity profile for compound 56. (A) Kinome scan with compound 56 at 500 nM. DYRK1A is highlighted (blue). (B) Activity of select kinases (ABL1, DYRK1A, AURKB, AURKA, MAP2K1, MAP2K2, and MELK) with OTS 167 5 (100 nM) or compound 56 (500 nM) as a percent of the control (DMSO-treated) activity.